Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-005097
Filing Date
2021-03-01
Accepted
2021-03-01 16:23:45
Documents
1
Period of Report
2021-02-25

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4111
  Complete submission text file 0001493152-21-005097.txt   5535
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
OncoCyte Corp (Issuer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 15 CUSHING IRVINE CA 92618
Business Address
Ross Douglas T. (Reporting) CIK: 0001808413 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37648 | Film No.: 21698117